GlassScriptPhysician profile
Jonathan A Swetech
NPI 1871909598
$1,656.86
in general payments reported to CMS, 2019-2025
20 companies · $852 in 2025
The $852 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $133 · 2024: $673 · 2025: $852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,524.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $574.15 | 2024-2025 | Airsupra |
| Heartflow, INC. | $132.51 | 2022 | |
| Medtronic, INC. | $121.98 | 2024 | Linq II |
| Globus Medical, INC. | $105.67 | 2025 | Senza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.81 | 2024 | Lifevest |
| Biotronik INC. | $94.61 | 2024 | Renamic Neo, Biomonitor |
| Bsn Medical INC | $72.38 | 2025 | |
| Novo Nordisk INC | $62.95 | 2025 | Ozempic, Rybelsus, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.28 | 2024-2025 | Xifaxan |
| Phathom Pharmaceuticals, INC. | $46.73 | 2024 | Voquezna |
| Intra-Sana Laboratories | $41.88 | 2024 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Antares Pharma, INC. | $41.80 | 2024-2025 | Xyosted |
| Hologic Sales and Service, LLC | $38.32 | 2025 | Aptima, Thinprep 2000 Processor |
| Inspire Medical Systems, INC. | $37.04 | 2025 | Inspire |
| Cipher Pharmaceuticals US LLC | $32.56 | 2025 | Spinosad, Natroba |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $30.96 | 2024 | Mounjaro, Zepbound |
| Saluda Medical Americas, INC. | $20.58 | 2025 | Evoke |
| Pfizer INC. | $19.49 | 2025 | |
| Exact Sciences Corporation | $16.79 | 2025 | The Cologuard Plus Collection Kit |
| Abbvie INC. | $15.37 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Swetech listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.